DRDO-Developed Drug '2-Deoxy-D-Glucose' Gets DCGI Approval for Emergency Use in Moderate to Severe COVID-19 Patients
The DCGI has granted permission for emergency use of therapeutic application of drug 2-deoxy-D-glucose (2-DG) as adjunct therapy in moderate to severe COVID-19 patients.
DRDO-Developed Drug '2-Deoxy-D-Glucose' Gets DCGI Approval for Emergency Use in Moderate to Severe COVID-19 Patients
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter (X), Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)